STAT+: Pharmalittle: We’re reading about a U.S. senator probing FDA, BioNTech founders leaving, and much more

BioNTech co‑founders Ugur Sahin and Özlem Türeci are exiting to launch a new, as‑yet‑unnamed mRNA company, while the original firm pivots to late‑stage cancer drugs and retains a minority stake in the spin‑off. Meanwhile, Republican Sen. Ron Johnson is pressing the FDA over recent denials of rare‑disease therapies, demanding written explanations and possible testimony.